Cux-1 is a murine homeobox gene that is highly and transiently expressed in the developing kidney. To further evaluate the role of Cux-1 in mammalian kidney development, organotypic cultures of embryonic mouse kidney were incubated with phosphorothioate-coupled antisense Cux-1 oligonucleotides ( 
Introduction
The definitive kidney in mammals, the metanephros, begins to develop during the fifth week of gestation in humans and 11.5 d postcoitus (d.p.c.) 1 in the mouse (1) . The metanephros has a dual origin from the ureteric bud and the metanephric blastema. During the development of the metanephros, the ureteric bud emerges from the caudal end of the mesonephric duct and invades the metanephric blastema. In response to an inductive signal from the branching ureteric bud, mesenchymal cells comprising the metanephric blastema condense and undergo epithelial differentiation forming a renal vesicle. The renal vesicle invaginates to form an S -shaped body that is the primordium of the glomerulus, proximal tubule, loop of Henle, and distal tubule. The collecting ducts, renal pelvis, and ureter are derived from the ureteric bud. Nephrogenesis involves multiple developmental processes including stem-cell differentiation, induction, mesenchymal-to-epithelial transformation, pattern formation, and apoptosis (2, 3) . During nephrogenesis, the expression of many genes is temporally and spatially regulated. However, only a few transcription factors that are essential for kidney development have been identified (4) (5) (6) .
Homeobox genes encode transcription factors that regulate developmental gene expression in many organisms. Cux-1 is a murine homeobox gene that is related to the Drosophila cut gene (7) . During mouse embryogenesis, Cux-1 is expressed in the developing excretory system including the mesonephros, mesonephric duct, and metanephros (8) . In the developing metanephros, Cux-1 is highly expressed at 13.5 d.p.c., which is shortly after metanephric induction commences, and expression remains high until the completion of nephrogenesis ‫ف‬ 1 wk postpartum. Thereafter, expression of Cux-1 decreases such that only low levels of expression are detected in the adult kidney. Studies using in situ hybridization have shown that Cux-1 is highly expressed in metanephric mesenchyme, induced epithelial structures (renal vesicle, S -shaped bodies), and ampullae of ureteric buds (8) . Expression of Cux-1 is downregulated during terminal differentiation, and Cux-1 is not detectable by in situ hybridization in mature tubules or glomeruli. This temporally and spatially restricted pattern of expression suggests that Cux-1 may play a role in kidney development.
Organotypic cultures of metanephric explants represent an excellent in vitro model for monitoring developmental processes during early nephrogenesis. When metanephroi are removed from embryos and placed in appropriate media, they continue to develop in vitro and display many of the processes of nephron induction and differentiation that are observed in vivo (9) (10) (11) . By incubating metanephric explants with antisense oligodeoxyribonucleotides (ODNs), the expression of specific genes can be inhibited and the consequences to kidney development can be monitored. Recently, the functions of Pax-2 and nerve growth factor receptor were studied in the developing kidney using antisense ODNs. Pax-2 is a paired-box protein that is highly expressed in condensed mesenchyme, S -shaped bodies, and ureteric ducts. Incubation of metanephric kidney cultures with antisense Pax-2 ODNs resulted in a block in nephrogenesis, and subsequent studies using gene targeting verified that Pax-2 null mice failed to form kidneys or ureters (5, 12) . Antisense inhibition of nerve growth factor receptor in organotypic kidney cultures perturbed both epithelial differentiation and branching morphogenesis (13) . In this paper, we report the use of antisense ODNs in organotypic metanephric cultures to examine the role of Cux-1 in kidney development.
Methods
Antisense oligonucleotides. 19-mer antisense ODNs were designed to target the translation start codon of Cux-1 (ASTr) corresponding to nucleotides 321-340 (accession number X75013; Genbank/EMBL/ DDBJ) or the homeobox (ASH) corresponding to nucleotides 3528-3547. The sequence of ASTr was 5 Ј -TTTGAGGTGGTGGACATCT-3 Ј , and the sequence of ASH was 5 Ј -TATGCTCGCTTCAGCGCTT-3 Ј . As negative controls, sense ODNs (STr, SH) were synthesized to the identical regions. The sequence of STr was 5 Ј -AGATGTCCACC-ACCTCAAA-3 Ј , and the sequence of SH was 5 Ј -AAGCGCT-GAAGCGAGCATA-3 Ј . Oligonucleotides were phosphorothioatecoupled and synthesized by the Yale Program in Critical Technologies. The ODNs were purified by HPLC to Ͼ 99% purity.
Organotypic kidney cultures. Organotypic kidney cultures were established from mouse embryos essentially as described previously (14) . Embryos were dissected from timed-pregnant mice at 12.5 d.p.c. Embryonic age was verified according to Theiler's criteria (15) . Metanephroi and associated ureteric buds were microdissected en bloc and placed in holding medium (L15 medium supplemented with 1 ϫ MITO ϩ serum extender). All media were supplemented with 100 U penicillin/ml and 0.1 mg streptomycin/ml.
Media containing antisense or sense ODNs were prepared as follows: 80 l of cationic liposomes (LipofectAmine; Life Technologies, Inc., Gaithersburg, MD) was added to 100 l of prewarmed (37 Њ C) Opti-MEM(Life Technologies, Inc.,). In a separate tube, an antisense ODN (ASTr or ASH) or a sense ODN (STr or SH) was added to 100 l of Opti-MEM to give a final concentration of 5 M ODN in 2 ml. The LipofectAmine and ODN mixtures were combined and preincubated for 45 min at room temperature. The LipofectAmine/ODN mixture was then added to DMEM-F12 medium supplemented with 5 ϫ MITO ϩ to give a final volume of 2 ml that was then added to each well of a six-well tissue culture plate containing Cyclopore (polyethylene terphthalate; Falcon Labware, Cockeysville, MD) inserts. Metanephroi were transferred from the holding media onto the surface of the Cyclopore membranes. For each treatment with antisense and sense ODNs, metanephroi from the same embryo were paired to control for any variability in gestational age. Cultures were incubated at 37 Њ C under an atmosphere of 5% CO 2 . After 24 h, the growth medium was replaced with fresh LipofectAmine and ODN mixtures prepared as described previously. After 52 h, the growth medium was supplemented with 10% fetal bovine serum. Metanephroi were examined daily by light microscopy and photomicrographs were obtained using a microscope (CK-2; Olympus Corp., Lake Success, NY). After 68 h, the metanephroi were washed briefly in PBS and fixed for morphology or terminal transferase-mediated dUTP nick end labeling (TUNEL) assay.
An additional 20 metanephroi were treated with antisense or sense ODNs in the absence of LipofectAmine. These metanephric explants were treated in an identical fashion to those described above, except that 10 M antisense (ASTr) or sense (STr) ODN was added to a final volume of 2 ml in DMEM-F12 supplemented with 5 ϫ MITO ϩ and antibiotics. Media were changed daily with addition of fresh ODN each time. Metanephroi were cultured for a total of 96 h and fixed.
Reverse Transcription-PCR. Reverse transcription of RNA and PCR amplification of cDNA (RT-PCR) was performed using the rTth Reverse Transcriptase RNA PCR Kit from Perkin Elmer Cetus Instruments (Foster City, CA). 11 sense and 11 antisense ODNtreated metanephroi were grown in culture for 68 h. Total RNA was purified using acid guanidinium thiocyanate-phenol-chloroform extraction (16). First strand cDNA synthesis was performed in a total volume of 20 l containing 10 mM Tris-Cl, pH 8.3, 100 mM KCl, 1 mM MnCl 2 , 200 M of each dNTP, 0.5 U of rTth DNA polymerase, 750 nM of an antisense Cux-1 -specific primer (5 Ј -TGGTTGGCTCGT-TCAAGGTCGGTCA-3 Ј ), and 165 ng of RNA. Reverse transcription was carried out by incubation at 65 Њ C for 9 min, followed by incubation at 70 Њ C for 6 min. The reaction was stopped by placing the tubes on ice, and 80 l of a PCR amplification reaction mix was added to give final concentrations of 8 mM Tris-Cl, pH 8.3, 4% glycerol, 80 mM KCl, 0.04% Tween 20, 0.6 mM EGTA, 1.5 mM MgCl 2 , and 150 nM Cux-1 -specific sense primer (5 Ј -TCAGGCCGAGAC-CATTGCTCTGGA-3 Ј ). PCR amplification was performed in a thermal cycler (Perkin Elmer Cetus Instruments) by incubation at 95 Њ C for 120 s followed by 30 cycles of incubation at 95 Њ C for 60 s and 60 Њ C for 60 s. After a final incubation at 60 Њ C for 7 min, samples were electrophoresed on a 3% NuSieve agarose gel, and products were visualized by ethidium bromide staining.
Morphologic studies. Metanephroi were fixed for 20 min at room temperature in PBS containing 1.5% glutaraldehyde and 5% sucrose. Metanephroi were postfixed in OsO 4 reduced with potassium ferrocyanide and embedded in epon. 1-m-thick sections were cut on a Leica Ultracut E ultramicrotome, stained with methylene blue and azure II, and then examined by light microscopy. Samples for electron microscopy were fixed similarly, embedded in epon, and cut into ultrathin (80-nm) sections. Sections were stained with lead citrate and examined with an Oberkochen electron microscope (D-7082; Carl Zeiss, Inc., Thornwood, NY).
For quantification of metanephric size, metanephroi treated with sense and antisense ODNs were photographed under light microscopy at identical magnification. Images were digitized using a film scanner (LS-1000; Nikon Inc., Melville, NY). Metanephroi were outlined manually, and the surface areas were calculated by pixel counting. The mean sizes of sense and antisense ODN-treated metanephroi were calculated for each experiment and compared using Student's two-tailed paired t test. Statistical significance was defined as P Ͻ 0.05.
TUNEL assay. Terminal transferase-mediated dUTP nick end labeling (17) was performed using the Fluorescein In Situ Cell Death Detection Kit from Boehringer Mannheim Biochemicals (Indianapolis, IN) according to the manufacturer's directions and as previously described (18) . Briefly, metanephroi were fixed in 4% paraformaldehyde at room temperature for 20 min and cryoprotected overnight with 30% sucrose in PBS. 8-m-thick cryosections were prepared using a Jung Frigocut cryostat (2800N; Leica Inc., Deerfield, IL). Sections were washed three times in PBS, permeabilized for 2 min on ice in PBS containing 0.1% sodium citrate and 0.1% Triton X-100, and then rinsed twice in PBS. Sections were overlaid with 50 l of labeling solution containing 30 mM Tris-Cl, pH 7.2, 140 mM sodium cacodylate, 1 mM CoCl 2 , 0.3 nmol fluorescein-12-dUTP, 3 nmol dATP, and 25 U terminal transferase. Slides were covered with a glass coverslip, incubated for 1 h at 37 Њ C in the dark, and then rinsed three times with PBS. Sections were mounted with Vectashield (Vector Laboratories, Inc., Burlingame, CA), and fluorescence microscopy was performed using a fluorescent microscope (Carl Zeiss, Inc.).
Materials. Timed-pregnant mice (strain CD-1) were from Charles River Laboratories (Wilmington, MA). The morning of detection of the copulatory plug was designated 0.5 d.p.c. Tissue culture growth media were from Life Technologies, Inc. MITO ϩ was from Collaborative Biomedical Inc. (Chicago, IL) and other media supplements were from Sigma Chemical Co. (St. Louis, MO). Agarose was from FMC BioProducts (Rockland, ME). Glutaraldehyde was from Electron Microscopy Sciences (Ft. Washington, PA). Other chemicals were of analytical or molecular biology grade from Baker (Sanford, ME) or Sigma Chemical Co.
Results
RT-PCR was performed to determine whether incubation of cultured metanephroi with Cux-1 antisense ODNs resulted in inhibition of Cux-1 expression. Fig. 1 shows that a PCR product of the predicted size (258 bp) could be amplified from RNA derived from metanephroi incubated with a sense Cux-1 ODN. In contrast, no product was obtained after amplification of RNA derived from metanephroi incubated with antisense Cux-1 ODNs. These results indicated that incubation with antisense (but not sense) ODNs inhibited Cux-1 expression.
Antisense and sense ODN-treated metanephroi were examined daily by light microscopy. Initially, all metanephroi were matched for gestational age and had a similar appearance (Fig. 2, A and B ) . By 48 h, the antisense ODN-treated metanephroi were visibly smaller and showed more prominent ureteric branches (Fig. 2 F , arrowheads ) , which was apparently due to loss of intervening tissue. Branching of the ureteric buds and development of nephron structures were observed in both antisense and sense ODN-treated metanephroi (Fig. 2, G  and H , arrows ) . However, fewer nephron structures developed in the antisense ODN-treated metanephroi. Similar results were seen in metanephroi treated with ODNs in the presence of cationic liposomes (Fig. 2, I and J ). The presence of cationic liposomes did not visibly affect the growth or morphology of sense ODN-treated metanephroi.
The surface areas of 24 sense and 24 matched antisense ODN-treated metanephroi from five separate experiments were compared. The mean size of sense and antisense ODNtreated metanephroi from each experiment (embryos from a single mother) were paired to control for minor variations in gestational age. Fig. 3 shows that the mean size of metanephroi incubated with antisense ODNs was 1.99 mm 2 , which was 23% less than the mean size of metanephroi incubated with sense ODNs (2.58 mm 2 ). This difference was statistically significant using Student's paired t test ( P ϭ 0.025). Fig. 4 A shows that metanephroi incubated with a sense ODN (STr) exhibited a normal pattern of differentiation in which all stages of metanephric development were visible including S -shaped bodies and ureteric buds (labeled S and UB , respectively, in Fig. 4 A ) . Fig. 4 B shows that metanephroi incubated with an antisense ODN (ASTr) also exhibited maturing nephron structures. However, antisense ODN-treated metanephroi also contained large regions of undifferentiatedappearing cells, many with pyknotic nuclei. These regions had fewer nephron structures, and some regions were devoid of recognizable nephric structures (Fig. 4 B , unlabeled arrow ) . At higher magnification, these regions contained shrunken cells with pyknotic nuclei, possibly representing apoptotic bodies (Fig. 4, C and D ) . Incubation with ASH, a different antisense ODN targeted to the homeobox, produced similar increases in apoptotic-appearing cells compared with a homeobox sense control ODN (data not shown). The antisense ODN-treated explants were visibly smaller than sense ODN-treated explants, which may be the result of cell loss due to apoptosis.
The most characteristic biochemical feature of apoptosis is chromatin cleavage (19) . The resultant nuclear DNA contains nicks that can be labeled enzymatically with fluorescein-12-dUTP using terminal transferase (TUNEL) (17, 18) . This procedure was performed to verify whether increased apoptosis was present in metanephroi after incubation with antisense ODNs. To validate the assay, we first performed TUNEL on sections of immature mouse kidney at 3 d postpartum. Previous studies by Coles et al. (20) indicated that apoptosis is present during normal kidney development. These authors used morphologic criteria to identify the presence of isolated apoptotic cells in the nephrogenic zone of the developing rat metanephros. Since nephrogenesis is ongoing at birth in rodents, we examined 3-d postpartum mouse kidney that contains a well-defined nephrogenic zone. Fig. 5 E shows that isolated cells in the subcortical nephrogenic zone were labeled by the TUNEL procedure (arrows), consistent with the results of Coles et al. and verifying the validity of the assay. Similar to the normal kidney of the developing mouse, metanephroi incubated in vitro with sense ODNs contained isolated cells that were labeled by the TUNEL method ( Fig. 5 C  and D) . However, metanephroi incubated with antisense ODNs exhibited a marked increase in labeled cells consistent with an increase in apoptosis (Fig. 5, G and H) . Due to the very high intensity of the fluorescence signal in the antisense ODN- treated metanephroi, it was not possible to enumerate the number of labeled cells for comparison with sense ODNtreated metanephroi. However, labeling of antisense ODNtreated metanephroi was qualitatively much greater than sense ODN-treated metanephroi. Moreover, large areas of labeled cells, corresponding to the regions of cells containing pyknotic nuclei observed by light microscopy, were seen in metanephroi incubated with antisense ODNs, but were never observed in metanephroi incubated with sense ODNs. In addition, incubation with either antisense ODN (ASTr or AH) produced similar results. To determine the location of apoptotic cells, metanephroi were examined by fluorescence and phase contrast microscopy ( Fig. 5) . Most of the apoptotic cells were present in the mesenchyme, although some labeled cells in S-shaped bodies and immature glomeruli were seen. No labeling was seen in tubular epithelial cells (Fig. 5 G, arrows) .
Cell death due to apoptosis can be distinguished from necrosis by characteristic ultrastructural features (21) . Initially, cells undergoing apoptosis exhibit cell shrinkage with crowding of organelles and condensation of chromatin, while the nuclear and plasma membranes remain intact. There is progressive condensation of chromatin with intense basophilic staining of the nuclei and nuclear fragmentation. Apoptotic bodies, which are small, membrane-bound bodies containing cytoplasmic and/or nuclear material are extruded into the intercellular space or undergo phagocytosis by neighboring cells. Accordingly, the regions of cell death observed in metanephroi treated with antisense ODNs were examined in greater detail by transmission electron microscopy. Fig. 6 shows that these regions contained shrunken cells in which the cell and nuclear boundaries were maintained and the nuclear chromatin was condensed into uniformly dense masses. In addition, numerous ovoid apoptotic bodies undergoing phagocytosis by neighboring cells were found in the mesenchyme (Fig. 6, arrow) . Marginal clumping of loosely textured chromatin, rupture of the nuclear membrane, swelling of intracellular organelles, and cell swelling and lysis, which are characteristic of necrotic cell death, were not observed.
Discussion
Previous studies demonstrated that the murine cut homologue, Cux-1, was highly and transiently expressed during early metanephrogenesis (8) . Since stage-dependent expression is charac- teristic of transcription factors that are important in nephrogenesis (e.g., WT-1, Pax-2), these studies suggested that Cux-1 may also be important during early nephrogenesis. To further evaluate whether Cux-1 was required for normal nephrogenesis, expression of Cux-1 was inhibited in vitro using antisense ODNs. The present study demonstrates that Cux-1 antisense ODNs perturb normal nephrogenesis in embryonic kidney cultures. Compared with metanephroi incubated with Cux-1 sense ODNs, metanephroi incubated with Cux-1 antisense ODNs were 23% smaller and contained a marked increase in the number of cells undergoing apoptosis as evidenced by light microscopy, electron microscopy, and TUNEL analysis. The increased cell death was due to inhibition of Cux-1 and was not due to nonspecific cytotoxicity, as indicated by the following: (a) two different antisense ODNs targeting distinct regions of the transcript produced an identical phenotype, (b) cell death was not increased in metanephroi incubated with two different sense ODNs, (c) a decrease in Cux-1 mRNA levels was observed in metanephroi treated with antisense ODNs, but not sense ODNs, and (d) cell death had characteristic biochemical and morphologic features of apoptosis rather than nonspecific tissue necrosis.
Metanephric explants incubated with antisense Cux-1 ODNs continue to exhibit branching of ureteric buds and development of epithelial structures including S-shaped bodies. Thus, Cux-1 antisense ODNs do not completely block nephrogenic induction. However, Cux-1 antisense ODN-treated metanephroi also contain regions of mesenchymal cell death that are devoid of epithelial structures. In contrast, antisense inhibition of Pax-2 results in a complete block of nephrogenic induction, absence of induced nephric structures, and decreased ureteric branching, but no evidence of increased apoptosis (12). Thus, the effects of antisense inhibition of Cux-1 and Pax-2 are distinct, suggesting that these transcription factors have different functions during nephrogenesis.
Apoptosis occurs during normal kidney development. Coles et al. (20) have reported that as many as 3% of cells in the nephrogenic zone and a smaller number of cells in the medullary papilla may be undergoing apoptosis at any given time during nephrogenesis. It is likely that apoptosis plays an important role in the selection of cells available for induction during mammalian nephrogenesis. Although apoptosis is present during normal nephrogenesis, Cux-1 antisense ODNtreated metanephroi show an abnormal increase in the number of apoptotic cells compared with sense ODN-treated metanephroi. Apoptotic cells were found predominantly in metanephric mesenchymal cells and to a lesser degree in early stage nephrons (renal vesicles and S-shaped bodies). No apoptotic cells were observed in tubular epithelial cells. Compared with epithelial cells, metanephric mesenchymal cells may be especially sensitive to inhibition of Cux-1 since Cux-1 is most highly expressed in this cell type and these cells are more permeant to antisense ODNs (8, 22) . Increased apoptosis has been observed after other experimental manipulations of kidney development. For example, 10-50% of the metanephric blastemal cells in WT-1 null mice are undergoing apoptosis, compared with 1% in wild-type embryos (4) . Incubation of metanephric cultures with neutralizing antibodies to hepatocyte growth factor causes an increase in cell death in the renal mesenchyme (23) . Metanephric mesenchymal cells placed in transfilter culture undergo apoptosis in the absence of inducing tissue, and cell death can be inhibited by epidermal growth factor (24) . These observations suggest that increased cell death in the developing kidney can result from both cell-and non-cellautonomous defects.
The expression of Cux-1 in the developing kidney is inversely related to the degree of nephron differentiation (8) . Transfection studies have shown that other mammalian cut homologues function as transcriptional repressors of genes specifying terminal differentiation in multiple cell lineages (7, (25) (26) (27) . These observations suggest that Cux-1 may function as a transcriptional repressor to inhibit terminally differentiated gene expression during early stages of nephrogenesis. Because the genes that are regulated by Cux-1 have not been identified in the developing kidney, the mechanism by which inhibition of Cux-1 leads to increased apoptosis remains unknown. However, the observation that inhibition of Cux-1 results in increased apoptosis is consistent with the notion that regulation of Cux-1 is required for normal nephron differentiation. One possibility is that inhibition of Cux-1 disturbs the normal relationship between cell proliferation and cell differentiation, which may result in apoptosis as a default pathway (28) .
In summary, incubation of murine metanephroi with two different Cux-1 antisense ODNs produces a marked increase in the number of cells undergoing apoptosis, predominantly in metanephric mesenchyme. These results suggest that proper regulation of Cux-1 expression may be necessary for normal kidney development. In addition, we report the first use of cationic liposomes to deliver ODNs to metanephroi in vitro. The use of cationic liposomes may reduce the quantity of phosphorothioate-coupled antisense ODN that is required to inhibit gene expression and thereby decrease the potential toxic effects of phosphorothioate ODNs.
